Dilating and fracturing side struts of open cell stents frequently used in pediatric cardiac interventions—An in vitro study by Krasemann, T. (Thomas) et al.
Received: 7 March 2018 | Revised: 16 July 2018 | Accepted: 17 July 2018
DOI: 10.1111/joic.12549
ORIGINAL INVESTIGATION
Dilating and fracturing side struts of open cell stents
frequently used in pediatric cardiac interventions—An
in vitro study
Thomas Krasemann MD (D), FRCP | Marco N. Kruit |
Arthur E. van der Mark | Martijn Zeggelaar | Michiel Dalinghaus MD |
Ingrid M. van Beynum MD
Division of Cardiology, Department of
Pediatrics, Sophia Kinderziekenhuis, Erasmus
Medical Centre Rotterdam, Rotterdam, The
Netherlands
Correspondence
Thomas Krasemann MD (D), FRCP, Sophia
Kinderziekenhuis, Division of Cardiology,
Department of Pediatrics, Erasmus Medical
Centre Rotterdam, Wytemaweg 80, 3015CN
Rotterdam, The Netherlands.
Email: t.krasemann@erasmusmc.nl
Background: Open cell stents are frequently used in interventional therapy of
congenital heart disease.Overstentingof vessel branchesmaynecessitate strutdilation.
Methods andResults:The strut size achievable in BardValeo andCookFormula stents,
and thepressurenecessary to fracture strutswas assessed. In addition, a self expanding
stent (Optimed SinusflexDS) was also tested. With the original balloon at nominal
pressure, in Valeo stents side struts could be dilated to approximately 90% of the
nominal stent diameter, in Formula stents to approximately 80%. With larger high
pressure woven balloons, strut size increased to approximately 125% in Valeo stents,
and to approximately 105% in the Formula. Strut fracture can connect two adjoining
struts. Pressures were dependent on the balloon utilized. Sidestruts of the Sinusflex
could lastingly overdilated with large balloons only.
Conclusion:Dilation and overdilation of side struts in open cell stents can be achieved.
Dependent on the clinical context, the original balloon used to place the premounted
stent can be used to achieve strut dilation, but woven high pressure balloons maybe
safer for patients. Should a larger diameter be required, these high pressure woven
balloons can achieve bigger diameters and even strut fracture.
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1 | INTRODUCTION
Stents are utilized in interventional therapy of congenital heart disease
since the 1980s.1 A broad variety of stents is used to treat stenosed
vessels, arteries as well as veins, and to keep created communications
open (ie, interatrial stent, Fontan tunnel fenestration).2,3
Stents can safely be redilated according to the patient's somatic
growth, but certain stents foreshorten substantially when overdilated.
Dependent on the design of the stent, foreshortening can be quite
extreme and dilation over a certain diametermay either not be possible
without the use of extreme high pressure balloons, or lead to stent
fracture.4,5
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In pediatric cardiology, many stents originally designed for other uses,
that is,peripheralvasculature, areused “off label.”Stentscanbecategorized
according to their design as closed cell or open cell. Open cell designed
stents can be placed over vessel bifurcations, allowing flow through the
struts into the covered vessel, while closed cell stents may jail the vessel
branch.6 There are numerous reports of dilation of these struts to allow
either stents placement in the overstented vessel itself, or simply to allow
better flowproperties. Thiswas first reported in the early 2000s.7 Balloons
used to achieve this vary in the literature, and little is known over the
possibly achievable diameter of ballooned side struts of open cell stents.
With our study, we wanted to measure the diameter achievable
with the same balloons used for stent deployment (for premounted
stents), the maximum strut diameter achievable, and the diameter of
two connected struts if one strut is fractured by means of ballooning.
We chose two stent types frequently used in pediatric interventional
practice (Valeo, BARD, Peripheral Vascular, Tempe, AZ, USA, and
Formula, Cook, Bloomington, USA), and a self expanding open cell
stent (Sinusflex DS, Optimed, Echjingen, Germany).
The Valeo stent is an open-cell stent with a triple helical
architecture.6 Its use in pediatric cardiac catheterization has well
been documented.6,8,9 Foreshortening during further dilating the stent
seems minimal.5,6 In one benchmark study, the struts were dilated
using two 12mm balloons side by side, and a maximum diameter of
12mm could be achieved.6 In clinical practice, a single balloon is
usually used to achieve strut dilation, and another balloon maybe
inflatedwithin the lumen tomaintain stent integrity. The Formula stent
is a stainless steel hybrid cell stent with different strut sizes.3 First
reports of its use in pediatric cardiac catheterization seem positive. As
the Valeo stent, it can be further dilated without much foreshorten-
ing.3,5 We were not able to find reports about dilating the struts.
We wanted to measure the diameters of dilated struts using the
original balloons on which the stents are premounted, the maximum
achievable diameter and the pressure needed to fracture struts.
Additionally, we tried to achieve strut overdilation in a self-expandable
stent (Sinusflex DS), as this is used in pediatric cardiology with an
increasing frequency, mainly to stent the arterial duct in hypoplastic
left heart, where overstenting of the distal aortic arch can occur, but as
well in other vessels.
2 | METHODS
Different sizes of premounted open cell stents (Valeo, BARD,
Peripheral Vascular and Formula, Cook) were inflated to nominal
diameter with the pressure advised by the manufacturers. The Cook
Formula stents have a different design from the Bard Valeo, as in the
former only two adjoining diamond shapes form an “open cell,”while in
the latter three diamonds form an “open cell” (Figure 1). An inflation
device (Encore 26, Boston Scientific, Marlborough, USA) was attached
to the balloon, and via a T-piece the pressure was also measured
exactly with an industrial pressure-transmitter (pressure probe DRTR,
B + B Thermo Technik GmbH, Donaueschingen, Germany). Once the
nominal pressure was achieved, the balloon was deflated.
The same (original) balloon was then passed through the struts
perpendicular to the axis of the stent, inflated to nominal pressure and
thenwithdrawn. This positionwas chosen to haveminimal interference
of the balloon position on the achievable diameter (Figure 2). The
diameter of the dilated strut was measured with a conventional
micrometer. A high pressure balloon (Conquest or Atlas gold [BARD
Peripheral Vascular], depending on the stent diameter) with a diameter
exceeding that of the original balloon was then positioned within these
dilated struts and inflated. Pressures necessary to achieve maximum
dilation were measured as well as the maximally achievable diameter of
the dilated struts. The maximum strut diameter was defined as the
diameter at which a further increase of the balloon pressure (of
the “oversized” balloon) did not enlarge the strut diameter further. The
balloon (or a bigger one, if necessary) was then re-inflated with such a
high pressure that the struts fractured. The pressure recordings were
done continuously to document the changes in pressure during strut
fracture. Then, the diameter of the two adjoining struts was measured.
In a second series (series 2), the balloonwas forwarded through one
side strut only and further through the lumen of the stent (Figure 2).
Similarly to thepreviousmeasurements, initially thediameter achievable
with the original balloon inflated to nominal pressure and the diameter
of the dilated strutweremeasured. Second, the balloonwas replacedby
ahighpressureballoonwhichwas inflated toachievemaximal dilationof
the strut, and then further until fracture occurred. Pressures to achieve
this were recorded, and achieved diameters measured.
In addition to balloon expandable premounted stents, we also
tested a self expanding stent, the SinusFlexDS, whichwas designed for
ductal stenting in duct-dependent systemic circulation (Optimed,
Ettlingen, Germany). Starting with a balloon of the same diameter as
the nominal stent diameter, we dilated the struts using the nominal
pressure for balloon inflation as per manufacturer's recommendation,
andmeasured the achieved diameter once the balloon was withdrawn.
With a balloon exceeding the diameter of the stent, struts were then
fractured similarly to the premounted balloon expandable stents. The
pressure necessary and the achieved diameter of two adjoining struts
was measured.
Descriptive statistics were used. Values are presented as means
and standard deviations, as appropriate. If percentages are used, these
refer to the nominal stent diameter achieved by inflating the balloon
expandable stents to nominal pressure, and the self expanding stent
nominal diameter, as appropriate.
As no patient data were used, there was no need to approve the
study by the institutional board according to the local guidelines.
3 | RESULTS
For the open cell stents, see Tables 1 and 2 for the achieved strut
diameter, balloons, and necessary pressures.
With the original balloons, in series 1 the achieved diameter of the
dilated struts of Valeo stents was smaller than the balloon diameter,
90 ± 6.3% when passing perpendicularly through the stent (series 1)
and 88 ± 4.8% when passed through one strut only (series 2).
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In the Formula stents, 77 ± 11.8% of the nominal stent diameter
could be achieved with the original balloon at nominal pressure in
series 1, and 95 ± 1.4% in series 2. It is noteworthy that the percentage
gets smaller with increasing stent sizes in series 1.
After inflating the stents to nominal diameter, the balloons
could be withdrawn from the lumen without damage and remained
intact. Forwarding the original balloon through the struts without
balloon damage was possible in all but one, which was the balloon
of a Cook Formula with a diameter of 5 mm. Here, the balloon was
punctured by the stent struts and could not be inflated. For further
testing, a Cook advance balloon of the same diameter (5 mm) was
then used.
Examples of the achieved results are shown in Figure 3.
To achieve the maximum diameter, relatively high pressures
were necessary. Woven balloons were used. They did not fracture,
but small punctures occurred. Interestingly, this did not lead to
notable pressure changes (Supplementary Figure S1). The maximal
achievable diameter in series 1 was 126.2 ± 4.5% of the nominal stent
diameter in the Valeo, and 79 ± 10.6% in the Formula stents (Table 1).
The maximal achievable diameter in series 2 was 123.5 ± 11% of the
nominal stent diameter in the Valeo, and 106 ± 5.7% in the Formula
stents (Table 1). Stent foreshortening occurred, but this was not
measured.
Pressures needed to fracture struts were dependent on the
balloon size: With larger balloon diameters, lower pressures were
needed to achieve strut fracture. Interestingly, pressure changes
occurring with strut fracture varied from less than one bar to two bar
(Supplementary Figure S2). We could not fracture struts of any Valeo
stents with 9mm Conquest balloons, but with an Atlas Gold balloon of
12mm diameter, we could achieve diameters of 11.2-11.8 mm of two
connected struts if the struts were fracturedwith this balloon. In case a
22mm balloon was used, the maximum diameter was 17mm in the
9 × 26mm Valeo, and the 10mm stent on an Atlas 22mm balloon
fractured with low pressures so that no useful measurements could be
achieved. Also, the lumen of the stent itself was compromised when
using oversized balloons (Figure 3).
FIGURE 1 Cell design of the Valeo and Formula stents
FIGURE 2 Balloon position in series 1 and series 2
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TABLE 1 Series 1
Stent Size
Diameter
NP
% nom
diameter
Diameter
max
% nom
diameter Balloon max
Pressure
max
Pressure
rupt
Diameter 2
struts
Valeo 6 × 26 5.2 87 7.9 131 Atlas Gold
12 × 40mm
1.1 7.8 11.6
Valeo 7 × 26 6.7 96 8.6 123 Atlas Gold
12 × 40mm
4.4 6.9 11.3
Valeo 8 × 26 7.8 98 9.6 120 Atlas Gold
12 × 40mm
6.3 7.3 11.8
Valeo 9 × 26 7.6 85 11.5 128 Atlas Gold
12 × 40mm
16.5 4.5** 17.0
Valeo 10 × 36 8.5 85 12.9 129 Atlas Gold
22 × 40mm
1.9 4.2
Cook
Formula
414
5 × 16 4.7* 94 4.7 94 Conquest 9 × 40 8.0 13
Cook
Formula
414
6 × 16 4.4 73 4.7 78 Conquest 9 × 40 4.9 9.8 8.3
Cook
Formula
535
8 × 12 5.7 71 5.7 71 Conquest 9 × 40 25.4 8.8*** 8.8
Cook
Formula
535
9 × 20 6.1 68 6.5 72 Conquest 9 × 40 7.1 7.4*** 8.8
Balloon max, balloon used to achieve maximum diameter (bar); Diameter max, maximal strut diameter (mm); Diameter NP, diameter at nominal pressure of
original balloon (mm); Diameter 2 struts, diameter of two struts connected due to strut rupture (mm); Pressure max, pressure used to achieve maximum
diameter (bar); Pressure rupt, pressure needed to rupture strut (bar); %nom diameter, percent of nominal stent diameter (%);.
*Original balloon ruptured. 5 mm Cook advance balloon used.
**Atlas Gold 22mm for rupture.
***Atlas Gold 12mm for rupture.
TABLE 2 Series 2
Stent Size
Diameter
NP
% nom
diameter
Diameter
max
% nom
diameter Balloon max
Pressure
max
Pressure
rupt
Diameter 2
struts
Valeo 7 × 26 5.8 82 9.0 129 Conquest
9 × 40mm
4.2 4.5*** 11.3
Valeo 8 × 26 7.5 93 8.5 107 Conquest
9 × 40mm
22.0 6.9*** 12.2
Valeo 9 × 26 7.7 86 11.6 129 Atlas gold
12 × 40mm
20.2 3.5** 17.1**
Valeo 10 × 36 9.1 90 12.9 129 Atlas Gold
22 × 40mm
2.0 3.3
Cook
Formula
414
5 × 12 4.7 94 5.5 110 Conquest 9 × 40 2.3 8.0 9.1
Cook
Formula
414
6 × 12 5.8 96 6.1 102 Conquest 9 × 40 9.7 9.8
Balloon max, balloon used to achieve maximum diameter (bar); Diameter max, maximal strut diameter (mm); Diameter NP, diameter at nominal pressure of
original balloon (mm); Diameter 2 struts, diameter of two struts connected due to strut rupture (mm); Pressure max, pressure used to achieve maximum
diameter (bar); Pressure rupt, pressure needed to rupture strut (bar); %nom diameter, percent of nominal stent diameter (%).
**Atlas Gold 22mm for rupture.
***Atlas Gold 12mm for rupture.
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In all Formula stents, fracture could be achieved with a Conquest
balloon of 9mm diameter. The 5mm stent lost integrity, but for all
others two adjoining struts had diameters between 8.3 and 9mm.
The struts of the self expandable 8mm stent could be dilated with
a Z-med II balloon of the same diameter as the stent (8 mm), but
interestingly after initially opening of the struts, the stent recoiled to
the original configuration again after approximately 5min. With a
slightly larger high pressure balloon (9mm Conquest, Bard) the struts
could be lastingly be overdilated using high pressures (12 bar). The
dilated struts here were not round as in the balloon expandable stents.
Fracture of a strut did not lead to further increase of the strut size, as
the stent reconfigured slightly (Figure 4).
4 | DISCUSSION
In all balloon expandable open cell stents, we could achieve
overdilation of struts easily. With the balloon provided by the
manufacturer inflated to nominal pressure, the diameter of the dilated
strut was in the range of approximately 80% of the nominal stent
diameter in the Cook Formula and approximately 90% in the Bard
Valeo stents. This seems less for the Formula stents and is dependent
on the cell design—in the Formula stent, the open cells are smaller than
in the Valeo (Figure 1). The maximally achievable diameter also differs,
probably for the same reason. Once the struts are dilated into a circular
shape (Figure 3), no further dilatation can occur as the metal itself is
non-stretchable.
In clinical practice, side struts of stents will hardly ever be crossed
perpendicularly as in series 1, but this approach allowed us to
determine strut properties without angulations of the balloon
influencing the result of the dilation. In most instances the stent will
be placed in a larger vessel (“main vessel”), and may overstent a
typically smaller branch (ie, the left subclavian artery in coarctation of
the aorta, or branches of the pulmonary artery in patients with branch
pulmonary artery stenosis). For such a situation, more than the
diameter achievable with the original balloon may not be necessary. If
dilation of a strut seems necessary during the implantation procedure,
the original balloon may be utilized to achieve this to save equipment.
On the other hand, one of the balloons (5 mm Cook Formula) was
damaged during crossing the struts. Woven balloons seem to keep
their integrity even when punctured.
The fact that in the Formula stents the maximum achievable
diameter of a strut was bigger in series 1 than in series 2 maybe due to
the oblique balloon position leading to deformation of the stents. We
did not measure foreshortening of the stent itself, as we focused on
strut diameters. In our in vitro series, the original balloon could be
easily withdrawn from overdilated struts. This may not reflect the
clinical situation, as the balloon withdrawal then is also influenced by
the vessel anatomy and mechanical properties of the vessel wall. Due
to bending, the balloon membrane may shear at the stent struts during
ballooning or withdrawal. Hence, our findings need to be interpreted
with caution. If during inflation (or withdrawal) balloon rupture
occurs—which maybe not longitudinally, but radially—this may lead to
FIGURE 3 Examples of the achieved results—maximum diameter of struts and strut fracture. Note that the maximum strut diameter in the
Formula stent is the same as the diameter achieved with nominal balloon pressure
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“parachuting” of the balloon parts, which then may make retrieval of
the balloon impossible. For patient safety, woven balloons offer better
security and can be recommended.
On theotherhand, thesewovenhighpressure balloons are typically
less soft and have a slightly higher profile. In our series they did not
fractureat all. Small puncturesdidnot lead to relevantpressure loss. This
seems to reflect clinical use, as they are frequently used not only in non-
compliant lesions, but also for stent redilation or strut-dilation.10 As the
choice of high pressure balloonswas limiteddue to availability, we could
not perform a stepwise increment of balloon sizes. It may be possible
that fracture can be achieved using less oversized balloons with higher
pressures. We saw that larger diameter balloons fractured stents at
lower pressures. In clinical practice it is unlikely that a balloon much
bigger than the nominal stent diameter is used, as the target vessel in
most caseswill be smaller than the vessel inwhich the stent is implanted.
With single balloons, we could achieve large diameters of the side
struts of Valeo stents, comparable to the diameter achieved by Travelli
et al who used two 12mmballoons used side by side.6We do not think
that a double balloon technique is necessary, and may complicate a
procedure further.
If over time a much larger diameter of the side strut is necessary,
then struts can be fractured using high pressure woven balloons.
Diameters of more than 1.5 times bigger than the diameter of the
Valeo stents can be achieved. This seems more dependent on the
balloon size than on the stent diameter.
In all tested Formula stents, we achieved strut fracture with 9mm
balloons, and the achieved diameter of two adjoining struts was in this
range. We did not test bigger balloons, hence do not know if a slightly
larger balloon would have achieved more. It is possible to overdilate
further, but then the stent loses integrity. For Valeo stents, comparably
bigger balloons are necessary to achieve fracture. The pressure
changes that occurred during strut fracture varied. For clinical practice
this means that they may not be visible immediately if pressure
measurements on conventional inflation devices are used. Fluoros-
copy will play a more important role to monitor progress. If high
pressure balloons are used and on careful inflation on fluoroscopy the
waist within the struts does not change anymore, the maximum
diameter is achieved. Further inflation may lead to strut rupture. The
shards may traumatize the vessel. Our in vitro study can, of course, not
answer this concern.
Stent foreshortening occurred both in Valeo and Formula stents,
but was not measured in our series, as it is a well known phenomenon
and has been tested in vitro.5 The struts of the self expanding stent
could be overdilated, but when dilated to the diameter of the stent
itself, it reconfigured within minutes. Only with high pressure and
larger balloon diameter, struts could be fractured and recoil did not
occur. In case a sidebranch of a vessel is overstented with this stent,
one should consider stenting through the struts, as described byKitano
et al for other stents.11
5 | LIMITATIONS
We did not have all possible sizes of the tested stents available. On the
other hand, the strut design is consistent throughout the models. The
balloons used for testingwere initially the balloons onwhich the stents
were premounted. In clinical practice, the choice maybe different, that
is, a small balloons maybe chosen first, followed by bigger ones.
Anyhow, we could show that woven high pressure balloons were able
to fracture stent struts, hence these balloons can be recommended if
larger diameters of struts are aimed for. The range of woven balloon
sizes used for testing was limited due to availability. Ideally, a catheter
laboratory is equipped with all types and all sizes of balloons, but this is
rarely achievable. Hence it is possible that slightly different strut
diameters could have been achieved with gradual upsizing of the
balloons. But as we think that the maximum achievable diameter
depends more on strut design than the diameter of the oversized high
pressure balloon, we accepted this limitation.
In clinical practice, balloon choice will vary dependent on the size
of the adjoining vessels and the diameters aimed for. Lastly, we
performed these testings in vitro and hence without supporting vessel
walls. While the mechanical properties of the stents alone will be the
same, they may behave differently in vivo.
6 | CONCLUSION
We could show in vitro that dilation and overdilation of side struts in
open cell stents can be achieved. Dependent on the clinical context,
the original balloon used to place the premounted stent can be used
FIGURE 4 Behavior of the self expanding Sinuspro DS stent—see
text.
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to achieve strut dilation, but woven high pressure balloons maybe
safer for patients. Should a larger diameter be required, these high
pressure woven balloons can achieve larger diameters and even strut
fracture.
For the self-expanding Sinusflex DS open cell stent, a balloon
larger than the nominal stent diameter was necessary to achieve a
lasting result. In clinical practice, where usually smaller vessels are
overstented, stenting through side struts can be recommended.
6.1 | Impact on daily practice
Knowledge of the properties of stents will help to overdilation and
fracture of sidestruts of cells in the treatment of congenital heart
disease. Depending on the strut design, Valeo stent struts can be
dilated to larger diameters than Formula stent struts. Self expanding
stent struts have a tendency to recoil.
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